289 related articles for article (PubMed ID: 19172850)
1. Effect of selol on the opioids activity in streptozotocin induced hyperalgesia.
Bujalska M; Winecka R; Gumułka SW
Acta Pol Pharm; 2008; 65(6):691-6. PubMed ID: 19172850
[TBL] [Abstract][Full Text] [Related]
2. Magnesium ions and opioid agonist activity in streptozotocin-induced hyperalgesia.
Bujalska M; Malinowska E; Makulska-Nowak H; Gumułka SW
Pharmacology; 2008; 82(3):180-6. PubMed ID: 18701828
[TBL] [Abstract][Full Text] [Related]
3. Effect of selenium compound (selol) on the opioid activity in vincristine induced hyperalgesia.
Bujalska M; Gumułka SW
Neuro Endocrinol Lett; 2008 Aug; 29(4):552-7. PubMed ID: 18766156
[TBL] [Abstract][Full Text] [Related]
4. Lycopene ameliorates thermal hyperalgesia and cold allodynia in STZ-induced diabetic rat.
Kuhad A; Chopra K
Indian J Exp Biol; 2008 Feb; 46(2):108-11. PubMed ID: 18335808
[TBL] [Abstract][Full Text] [Related]
5. Decreased basal endogenous opioid levels in diabetic rodents: effects on morphine and delta-9-tetrahydrocannabinoid-induced antinociception.
Williams J; Haller VL; Stevens DL; Welch SP
Eur J Pharmacol; 2008 Apr; 584(1):78-86. PubMed ID: 18313663
[TBL] [Abstract][Full Text] [Related]
6. Spinal orexin-1 receptors mediate anti-hyperalgesic effects of intrathecally-administered orexins in diabetic neuropathic pain model rats.
Kajiyama S; Kawamoto M; Shiraishi S; Gaus S; Matsunaga A; Suyama H; Yuge O
Brain Res; 2005 May; 1044(1):76-86. PubMed ID: 15862792
[TBL] [Abstract][Full Text] [Related]
7. Antihyperalgesic effects of cizolirtine in diabetic rats: behavioral and biochemical studies.
Aubel B; Kayser V; Mauborgne A; Farré A; Hamon M; Bourgoin S
Pain; 2004 Jul; 110(1-2):22-32. PubMed ID: 15275748
[TBL] [Abstract][Full Text] [Related]
8. Emblica officinalis corrects functional, biochemical and molecular deficits in experimental diabetic neuropathy by targeting the oxido-nitrosative stress mediated inflammatory cascade.
Tiwari V; Kuhad A; Chopra K
Phytother Res; 2011 Oct; 25(10):1527-36. PubMed ID: 21394805
[TBL] [Abstract][Full Text] [Related]
9. Tapentadol, but not morphine, selectively inhibits disease-related thermal hyperalgesia in a mouse model of diabetic neuropathic pain.
Christoph T; De Vry J; Tzschentke TM
Neurosci Lett; 2010 Feb; 470(2):91-4. PubMed ID: 20026182
[TBL] [Abstract][Full Text] [Related]
10. Specific antinociceptive activity of cholest-4-en-3-one, oxime (TRO19622) in experimental models of painful diabetic and chemotherapy-induced neuropathy.
Bordet T; Buisson B; Michaud M; Abitbol JL; Marchand F; Grist J; Andriambeloson E; Malcangio M; Pruss RM
J Pharmacol Exp Ther; 2008 Aug; 326(2):623-32. PubMed ID: 18492948
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of antinociceptive effect of morphine by antidepressants in diabetic neuropathic pain model.
Cegielska-Perun K; Bujalska-Zadrożny M; Gąsińska E; Makulska-Nowak HE
Pharmacol Rep; 2014 Apr; 66(2):228-34. PubMed ID: 24911074
[TBL] [Abstract][Full Text] [Related]
12. Effects of sevoflurane on carrageenan- and fentanyl-induced pain hypersensitivity in Sprague-Dawley rats.
Richebé P; Rivalan B; Rivat C; Laulin JP; Janvier G; Maurette P; Simonnet G
Can J Anaesth; 2009 Feb; 56(2):126-35. PubMed ID: 19247760
[TBL] [Abstract][Full Text] [Related]
13. Bradykinin receptors antagonists and nitric oxide synthase inhibitors in vincristine and streptozotocin induced hyperalgesia in chemotherapy and diabetic neuropathy rat model.
Bujalska M; Makulska-Nowak H
Neuro Endocrinol Lett; 2009 Mar; 30(1):144-52. PubMed ID: 19300402
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin type A reduces pain supersensitivity in experimental diabetic neuropathy: bilateral effect after unilateral injection.
Bach-Rojecky L; Salković-Petrisić M; Lacković Z
Eur J Pharmacol; 2010 May; 633(1-3):10-4. PubMed ID: 20123097
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of different fractions of Calotropis procera (Asclepiadaceae) in streptozotocin induced experimental model of diabetic neuropathy.
Yadav SK; Nagori BP; Desai PK
J Ethnopharmacol; 2014 Mar; 152(2):349-57. PubMed ID: 24486599
[TBL] [Abstract][Full Text] [Related]
16. Effects of the endocannabinoid transport inhibitors AM404 and UCM707 on diabetic neuropathy in rats.
Hasanein P; Soltani N
Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1127-31. PubMed ID: 19413593
[TBL] [Abstract][Full Text] [Related]
17. Relevance of hyperglycemia to early mechanical hyperalgesia in streptozotocin-induced diabetes.
Romanovsky D; Hastings SL; Stimers JR; Dobretsov M
J Peripher Nerv Syst; 2004 Jun; 9(2):62-9. PubMed ID: 15104693
[TBL] [Abstract][Full Text] [Related]
18. Antinociceptive efficacy of lacosamide in a rat model for painful diabetic neuropathy.
Beyreuther B; Callizot N; Stöhr T
Eur J Pharmacol; 2006 Jun; 539(1-2):64-70. PubMed ID: 16682022
[TBL] [Abstract][Full Text] [Related]
19. Orofacial sensory changes after streptozotocin-induced diabetes in rats.
Nones CF; Reis RC; Jesus CH; Veronez DA; Cunha JM; Chichorro JG
Brain Res; 2013 Mar; 1501():56-67. PubMed ID: 23313875
[TBL] [Abstract][Full Text] [Related]
20. Nociception, antinociceptive potency of morphine in streptozotocin induced diabetic rats.
Mahajan AS; Chakrabarty K; Mishra TK; Chakrabarty AS
Indian J Physiol Pharmacol; 1997 Oct; 41(4):416-20. PubMed ID: 10235666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
